If you have an account please sign in to continue
Dialog Box
Funding innovative research to detect and treat ovarian cancer and save women’s lives.
This record funding demonstrates the OCRF’s dedication to shining a light on ovarian cancer; leading to a future without fear of ovarian cancer.
Until 31 December 2019, AFT Pharmaceuticals will donate $1 of every Maxigesic pack sold to one of three charity partners including the OCRF.
Discover who we are, what we do and how your support can help change the statistics for Australian women.
What we do
Learn about the silent killer that claims another Australian life every eight hours.
Learn the facts
Through innovative ovarian cancer research, we aim to improve the lives of women with ovarian cancer today and increase survival rates in the future.
Discover our vision
Research relies on your support. Find out how you can fundraise on our behalf, show your support to our partners, or use your voice to spark action.
Find out more
"I want my daughter and her friends to be able to grow up and have a test for ovarian cancer as part of their regular health check-up. I don’t want them to fear this. It’s not going to save my life, but it might just save hers or one of her friends."
OCRF Ambassador Kel Pittman
$43,300 raised so far
$30,954 raised so far
$23,572 raised so far
News
The 2019 Silver Style event was held on the 13th of November at Eureka 89.
When Carla’s mother Suzanne discovered she had Stage 4 Ovarian Cancer in November 2012, her family support team flew into action.
Over the past decade, OCRF-funded researcher Professor Pradeep Tanwar has helped advance our understanding of the link between female reproductive hormone and how they can help women lower their risk of ovarian cancer.
On 6 September, 820 supporters gathered in Mackay, Queensland for the annual Nude Lunch.
Please enter a valid email address